Use of biomarkers in epidemiologic studies: minimizing the influence of measurement error in the study design and analysis

[1]  B Rosner,et al.  Correction of logistic regression relative risk estimates and confidence intervals for systematic within-person measurement error. , 2006, Statistics in medicine.

[2]  A. Ashworth,et al.  Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer: a systematic review. , 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[3]  S. Hankinson,et al.  Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. , 2004, Journal of the National Cancer Institute.

[4]  F. Stanczyk.  Extraction/chromatographic testosterone RIA can be used as the "gold standard" for determining the reliability of direct testosterone immunoassay measurements. , 2004, Clinical chemistry.

[5]  B. Rosner,et al.  Plasma Prolactin Concentrations and Risk of Postmenopausal Breast Cancer , 2004, Cancer Research.

[6]  S. Hankinson,et al.  Insulin-like growth factors and neoplasia , 2004, Nature Reviews Cancer.

[7]  A. McTiernan,et al.  Specimen allocation in longitudinal biomarker studies: controlling subject-specific effects by design. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[8]  Francine Laden,et al.  Epidemiology of urinary melatonin in women and its relation to other hormones and night work. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[9]  C. Ulrich,et al.  Association of CYP17, CYP19, CYP1B1, and COMT Polymorphisms with Serum and Urinary Sex Hormone Concentrations in Postmenopausal Women , 2004, Cancer Epidemiology Biomarkers & Prevention.

[10]  F. Stanczyk,et al.  Limitations of direct estradiol and testosterone immunoassay kits , 2003, Steroids.

[11]  Brenda Eskenazi,et al.  Biological sample collection and processing for molecular epidemiological studies. , 2003, Mutation research.

[12]  E. Rimm,et al.  Adiponectin: stability in plasma over 36 hours and within-person variation over 1 year. , 2003, Clinical chemistry.

[13]  Stefano Bonassi,et al.  Methodological issues in pooled analysis of biomarker studies. , 2002, Mutation research.

[14]  T. Key,et al.  Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. , 2002, Journal of the National Cancer Institute.

[15]  D. Palmer-Toy,et al.  Compatibility of the Abbott IMx homocysteine assay with citrate-anticoagulated plasma and stability of homocysteine in citrated whole blood. , 2001, Clinical chemistry.

[16]  A. Ciampi,et al.  Reliability and validity of commercially available, direct radioimmunoassays for measurement of blood androgens and estrogens in postmenopausal women. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[17]  D. Moher,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. , 2001, Journal of the American Podiatric Medical Association.

[18]  J. Livesey,et al.  Effect of anticoagulants and storage temperatures on stability of plasma and serum hormones. , 2001, Clinical biochemistry.

[19]  I. Olkin,et al.  Improving the Quality of Reports of Meta-Analyses of Randomised Controlled Trials: The QUOROM Statement , 2000, Oncology Research and Treatment.

[20]  S. Humphries,et al.  Effects of sample handling on the stability of interleukin 6, tumour necrosis factor-alpha and leptin. , 2000, Cytokine.

[21]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[22]  J. Manson,et al.  Reproducibility of plasma and urinary sex hormone levels in premenopausal women over a one-year period. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[23]  I. Olkin,et al.  Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement , 1999, The Lancet.

[24]  R. Hoover,et al.  Reproducibility and validity of radioimmunoassays for urinary hormones and metabolites in pre- and postmenopausal women. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[25]  David J Hunter,et al.  Circulating concentrations of insulin-like growth factor I and risk of breast cancer , 1998, The Lancet.

[26]  D Spiegelman,et al.  Measurement error correction for logistic regression models with an "alloyed gold standard". , 1997, American journal of epidemiology.

[27]  L. Shamel,et al.  Stability of free prostate-specific antigen in serum samples under a variety of sample collection and sample storage conditions. , 1996, Urology.

[28]  S. Greenhut,et al.  Reliability and validity of serum sex hormone measurements. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[29]  R. Hoover,et al.  Reproducibility studies and interlaboratory concordance for assays of serum hormone levels: estrone, estradiol, estrone sulfate, and progesterone. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[30]  G A Colditz,et al.  Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. , 1995, Journal of the National Cancer Institute.

[31]  A. Wilcox.  Molecular epidemiology: collision of two cultures. , 1995, Epidemiology.

[32]  J. Manson,et al.  Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[33]  F. Berrino,et al.  Validity for epidemiological studies of long-term cryoconservation of steroid and protein hormones in serum and plasma. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[34]  Re Waller,et al.  Principles of Exposure Measurement in Epidemiology , 1994 .

[35]  G W Comstock,et al.  Reported effects of long-term freezer storage on concentrations of retinol, beta-carotene, and alpha-tocopherol in serum or plasma summarized. , 1993, Clinical chemistry.

[36]  B Rosner,et al.  Correction of logistic regression relative risk estimates and confidence intervals for random within-person measurement error. , 1992, American journal of epidemiology.

[37]  E. Baráth,et al.  Fundamentals of Biostatistics. , 1992 .

[38]  B G Armstrong,et al.  The effects of measurement errors on relative risk regressions. , 1990, American journal of epidemiology.

[39]  B Rosner,et al.  Correction of logistic regression relative risk estimates and confidence intervals for measurement error: the case of multiple covariates measured with error. , 1990, American journal of epidemiology.

[40]  S. Chinn,et al.  The assessment of methods of measurement. , 1990, Statistics in medicine.

[41]  C. Chute,et al.  Effect of transport conditions on the stability of biochemical markers in blood. , 1989, Clinical chemistry.

[42]  A A Tsiatis,et al.  The impact that group sequential tests would have made on ECOG clinical trials. , 1989, Statistics in medicine.

[43]  M. Stampfer,et al.  Some factors affecting determination of carotenoids in serum. , 1984, Clinical chemistry.

[44]  C. Mettlin,et al.  Vitamin A and lung cancer. , 1979, Journal of the National Cancer Institute.

[45]  S. Hankinson,et al.  Insulin-like growth factor and breast cancer risk: evidence from observational studies. , 2003, Breast disease.

[46]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. , 2000, JAMA.

[47]  M. Katan.  Biochemical indicators of dietary intake. , 1998 .

[48]  M T Landi,et al.  Sample collection, processing and storage. , 1997, IARC scientific publications.

[49]  P. Vineis,et al.  Sources of variation in biomarkers. , 1997, IARC scientific publications.

[50]  E White,et al.  Effects of biomarker measurement error on epidemiological studies. , 1997, IARC scientific publications.

[51]  J. Manson,et al.  Laboratory reproducibility of endogenous hormone levels in postmenopausal women. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[52]  A. Smith,et al.  Serum vitamin A (retinol) and cancer incidence in Evans County, Georgia. , 1981, Journal of the National Cancer Institute.